PARKE DAVIS FDA Approval ANDA 083625

ANDA 083625

PARKE DAVIS

FDA Drug Application

Application #083625

Application Sponsors

ANDA 083625PARKE DAVIS

Marketing Status

Discontinued001

Application Products

001TABLET;ORAL25MG0TRIPELENNAMINE HYDROCHLORIDETRIPELENNAMINE HYDROCHLORIDE

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 83625
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.